4.2 Article

Proteomic profile of vitreous in patients with tubercular uveitis

Journal

TUBERCULOSIS
Volume 126, Issue -, Pages -

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.tube.2020.102036

Keywords

Tubercular uveitis; Tuberculosis; Uveitis; Extrapulmonary tuberculosis; Shotgun proteomics; Vitreous

Funding

  1. Fogarty AIDS International Training and Research Program (AITRP)
  2. New York University of School of Medicine (NYUSoM)
  3. Graduate Partnership Program (GPP) of the NIH
  4. American Association of Pharmaceutical Scientists (AAPS) foundation
  5. European Union under the European Regional Development Fund [MAB/2017/03]
  6. Intramural Research program of NIAID, NIH

Ask authors/readers for more resources

The protein profile in vitreous fluid of patients with TBU differs significantly from non-TBU patients and controls, involving different metabolic and signaling pathways. This differential protein profile provides new insights into the molecular mechanisms of TBU and lays the foundation for exploring biomarkers to differentiate TBU.
Objective: To elucidate disease-specific host protein profile in vitreous fluid of patients with intraocular inflammation due to tubercular uveitis (TBU). Methods: Vitreous samples from 13 patients with TBU (group A), 7 with non-TBU (group B) and 9 with no uveitis (group C) were analysed by shotgun proteomics using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Differentially expressed proteins (DEPs) were subjected to pathway analysis using WEB-based Gene SeT Analysis Toolkit software. Results: Compared to control groups (B + C combined), group A (TBU) displayed 32 (11 upregulated, 21 downregulated) DEPs, which revealed an upregulation of coagulation cascades, complement and classic pathways, and downregulation of metabolism of carbohydrates, gluconeogenesis, glucose metabolism and glycolysis/gluconeogenesis pathways. When compared to group B (non-TBU) alone, TBU displayed 58 DEPs (21 upregulated, 37 downregulated), with an upregulation of apoptosis, KRAS signaling, diabetes pathways, classic pathways, and downregulation of MTORC1 signaling, glycolysis/gluconeogenesis, and glucose metabolism. Conclusion: This differential protein profile provides novel insights into the molecular mechanisms of TBU and a baseline to explore vitreous biomarkers to differentiate TBU from non-TBU, warranting future studies to identify and validate them as a diagnostic tool in TBU. The enriched pathways generate interesting hypotheses and drive further research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available